Here are relevant reports on : in-vivo-cro-market
-
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019
The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019. Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the molecular weight markers market.
- Published: February 2015
- Price: $ 4950
- TOC Available:
-
Compound Management Market by Product & Outsourcing Services (Instruments (Automated Storage, Decapper), Software), Sample (Chemical Compounds, Biological Samples), End User (Biopharma Companies, Biobank, Pharma Companies, CRO) - Global Forecasts to 2023
The global compound management market is projected to reach USD 424.5 million in 2023, at CAGR of 14.5%. Increasing drug discovery activities, growing biopharmaceutical industry, and rising trend in outsourcing compound/sample management are the factors supporting the growth of this market. On the other hand, the large capital investments needed to establish compound management facilities is the major factor limiting market growth. The compound management market is highly competitive due to the presence of a large number of players. Few companies that provide compound management systems are Brooks Life Sciences (US), Hamilton Company (US), TTP Group (UK), Labcyte (US), Biosero (US), and Tecan (Switzerland).
- Published: August 2018
- Price: $ 4950
- TOC Available:
-
Gene Therapy Market by Type (Gene silencing), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Gene Type (Receptors, Cytokine), Therapeutic Area (Oncology, Neurology), Delivery Method (In-Vivo, Ex-Vivo), RoA (IV) - Global Forecast to 2032
The global gene therapy market, valued at US$7.21 billion in 2023, stood at US$8.85 billion in 2024 and is projected to advance at a resilient CAGR of 19.4% from 2025 to 2032, culminating in a forecasted valuation of US$36.55 billion by the end of the period. Market growth is attributed to factors such as the growing demand for curative therapies for genetic disorders, rare diseases, and specific types of cancer, robust clinical trial pipeline for gene therapy and increasing investments in gene therapy research.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Nanorobotics Market Size, Share & Trends by Type (Nano-manipulator, Nanorobotic System), Deployment (In-vivo, In-vitro/Ex-vivo, Others), Technology (Magnetic Actuation, Biohybrid/Biological Propulsion, Acoustic/Ultrasound Propulsion, Others)-Global Forecast to 2032
The global nanorobotics market is projected to grow from USD 2.27 billion in 2025 to USD 4.52 billion by 2032, expanding at a CAGR of 10.6% during the forecast period. The Key companies operating in the nanorobotics market include Bruker (Germany), Thermo Fisher Scientific Inc. (US), Hitachi High-Tech Corporation (Japan), JEOL LTD. (Japan), ZEISS Group (Germany), Oxford Instruments (UK), CIQTEK Co., Ltd (China).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
New Approach Methodologies (NAMs) Market By Offering (Product, Service), Method (In Vitro (2D, 3D), OOC/MPS, In Silico, Ex Vivo), Application (Drug Development, Toxicology Testing), End User (Pharma & Biotech Companies) – Global Forecast To 2031
New Approach Methodologies (NAMs) Market
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Small Animal Imaging (In-Vivo) Market by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global Forecast to 2021
The global small animal imaging market is expected to reach a value of USD 910.4 Million by 2021; growing at a CAGR of 6.2% during 2016-2021. A number of factors such as technological advancements in the field of molecular imaging, increasing market demand for non-invasive small animal imaging techniques, and growing number of public-private initiatives and funding to support preclinical researches are propelling the growth of the global small animal imaging market.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
In Vivo Toxicology Market Size, Share & Trends by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) & Region - Forecast to 2025
The size of global in vivo toxicology market in terms of revenue was estimated to be worth $5.0 billion in 2020 and is poised to reach $6.6 billion by 2025, growing at a CAGR of 11.5% from 2020 to 2025. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.
- Published: March 2021
- Price: $ 4950
- TOC Available:
-
Sustained Release Coatings Market by Application (In Vitro, In Vivo), Substrate Type (Tablets, Capsules, Pills), Polymer Material Type (Ethyl & Methyl Cellulose, Polyvinyl & Cellulose Acetate, Methacrylic Acid, PEG), and Region - Global Forecast to 2024
The sustained release coating market size is projected to grow from USD 478 million in 2019 to USD 660 million by 2024, at a CAGR of 6.6% during the forecast period. With the increasing demand for microencapsulated products, significant R&D activities are being carried out by various companies in the market, thus aiding the growth of the sustained release coating market. New technologies, such as sustained release coating, are required to tap niche markets in cancer and brain tumor-specific drug delivery.Colorcon (US), BASF (Germany), Evonik (Germany), and Coating Place (US).
- Published: June 2019
- Price: $ 4950
- TOC Available:
-
Biophotonics Market by Application(See-through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), Technology(In-vivo, In-vitro), End-use(Diagnostics, Therapeutic, Tests), & Geography - Global Growth Driver and Industry Forecast to 2035
The overall market for biophotonics in 2014 was valued at USD 26.26 Billion, which is estimated to reach USD 50.18 Billion by 2020, at a CAGR of 11.5% during the forecast period. This market growth can be attributed to emergence of nanotechnology, significant technological advancements over the last few years and their adoption in the medical sector, increase in the demand for home-based POC devices, aging population, and growing lifestyle diseases.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
US eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech) Regulatory, Al, Growth, Market Size - Forecast to 2030
US eClinical solutions market, valued at US$5.26 billion in 2024, stood at US$5.99 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2025 to 2030, culminating in a forecasted valuation of US$11.64 billion by the end of the period. The growth is driven by the rising number of clinical trials conducted across major research hubs, particularly in oncology, immunology, and rare diseases.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
